Articles 7 Questions: Jörg Land on the first reimbursed mobile app in... Jörg Land talks about the approval process for a new app technology for treating tinnitus, the first ever to be reimbursed in Germany
News CRISPR biotech Intellia cuts staff as it eyes 2027 launch Eyeing a first commercial launch in 2027, Intellia is re-prioritising by cutting 27% of its workforce and shelving a lung disease candidate.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.